Search Results for "bortezomib"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for bortezomib. Results 1 to 2 of 2 total matches.
See also: Velcade
Isatuximab (Sarclisa) for Multiple Myeloma (online only)
The Medical Letter on Drugs and Therapeutics • Dec 09, 2024 (Issue 1717)
.
Patients were randomized to receive isatuximab
in addition to standard treatment (bortezomib ...
Isatuximab-irfc (Sarclisa – Sanofi), a CD38-directed
cytolytic antibody, has been approved by the FDA for
treatment of newly diagnosed multiple myeloma in
adults who are not eligible for autologous stem cell
transplantation (ASCT). The drug was approved earlier
for treatment of relapsed or treatment-refractory
multiple myeloma.
Med Lett Drugs Ther. 2024 Dec 9;66(1717):e200-1 doi:10.58347/tml.2024.1717e | Show Introduction Hide Introduction
Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023 (Issue 1669)
delavirdine
fluconazole
fluvoxamine
ticlopidine
abiraterone
armodafinil
bortezomib
cannabidiol ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30 doi:10.58347/tml.2023.1669g | Show Introduction Hide Introduction